Consortium research has produced the first systematic and comprehensive recommendations and analysis on protecting human participants in research on nanomedicine products, including drugs, devices, and gene therapy using nano-vectors. The recommendations appear in a symposium published in the current issue of The Journal of Law, Medicine & Ethics, now available online. The research raised significant questions about how to protect human subjects and others exposed to nanomaterials in the course of research. The symposium was part of a NIH/NHGRI-funded nanomedicine ethics project that included the conference, Nanodiagnostics and Nanotherapeutics: Building Research Ethics and Oversight. Project PI’s were University of Minnesota professors Susan M. Wolf, JD, Jeffrey McCullough, MD, and Ralph Hall, JD, and Jeffrey Kahn, PhD, from Johns Hopkins' Berman Center for Bioethics.
Saturday, December 1, 2012